Share More evidence mounts supporting the causal role of gadolinium containing MRI contrast agents and nephrogenic systemic fibrosis (NSF) in patients on dialysis. Two papers in the June 2008 issue of the American Journal of Kidney Diseases examine the issue. Kallen, et all report that “Receipt of gadolinium-containing MRI contrast is associated with NSF in…
Recommend this site on Facebook: